NTI 0.00% 7.1¢ neurotech international limited

Primary outcome [1] - Change in Clinical Global Impression Scale...

  1. 1,420 Posts.
    lightbulb Created with Sketch. 565


    Primary outcome [1] - Change in Clinical Global Impression Scale -Improvement (CGI-I)This is a 7-point scale measuring symptom change from baseline

    Primary outcome 2 - Change in Vineland Adaptive Behaviour Scales, Third Edition (Vineland-3) Parent/Caregiver Form.Used to measure adaptive functioning across three core domains (Communication, Daily Living Skills, and Socialization), and two optional domains (Motor Skills and Maladaptive Behaviour); items are rated on a 3-point scale (0=never; 1=sometimes; 2=usually or often). The core domains sum to a total Adaptive Behaviour Composite.

    There are Many secondary outcomes / measures. Very comprehensive so gives (me) an understanding of why it takes so long to compile the results and understand drivers for any outliers. There will be a cornucopia of other data collected against the above measures for other trials to compare to. Also blood as youve mentioned, liver and renal tests for safety.

    All the detail here: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381885&isReview=true although updating the CTR site isnt one of NTI or Fenix's strong points.

    GLAH
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.000(0.00%)
Mkt cap ! $72.23M
Open High Low Value Volume
7.3¢ 7.3¢ 7.1¢ $38.20K 537.9K

Buyers (Bids)

No. Vol. Price($)
1 47175 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 100000 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.